Acar & Ergönen acted as sell-side legal advisor in Koç Holding’s acquisition of a 65% stake in StemBio

We have advised StemBio, a pioneering leader in biotechnology, regenerative medicine, and cord blood banking, in this transaction. This deal marks a pivotal milestone, shaping the future of biotechnology and innovation in Turkey. We are honored to contribute to an achievement that underscores StemBio’s visionary approach and the transformative potential of this sector.